Langoyan, Dario S.
HRN: 21-95-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
10/13/2022
10/13/2022
TOPICAL
1%
3
Wound Debridement
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes